Introduction
COPD is a disease characterized by airflow limitation that is not fully reversible. As a major public health problem, COPD is the third leading cause of death in China. 1 
Patients and methods study design and patients
This study was a retrospective database analysis. Nationwide cross-sectional surveys of patients with COPD were conducted in China including eleven tertiary hospitals from September 2007 to December 2008. These eleven hospitals were chosen because they represented different parts of China. The study was approved by the ethical committee of Peking University Third Hospital, Beijing, China. All data in the database were de-identified.
Patients' survey
Outpatients with COPD were recruited consecutively. COPD was diagnosed according to the criteria recommended by the Chinese Medical Society. 19 Chronic airflow limitation was defined as a post-bronchodilator ratio of FEV 1 /FVC being 70%. Bronchodilator reversibility test revealed an increase in FEV 1 12% or 200 mL above the pre-bronchodilator FEV 1 after inhalation of 400 µg of salbutamol. Static lung volumes were measured in all patients using body plethysmography when appropriate. Patients were asked if they had comorbidities such as hypertension, coronary artery disease, diabetes, cerebrovascular disease, or other diseases. Patients with asthma, bronchiectasis, lung cancer, active lung tuberculosis, psychiatric diseases, cognitive dysfunction, or left heart failure were excluded from the study. Information on the use of drugs was also acquired by asking patients. The Chinese validated version of short form-36 (SF-36) was administered by trained researchers in each center. 20 Each patient was interviewed once.
Questionnaire items
The questionnaire was designed according to the literature with modification. A panel of COPD experts helped draft the questionnaires. The demographics, and patients' knowledge, attitude, and practice of COPD were included in the questionnaire. Patients' knowledge, attitude, and practice on COPD diagnosis and treatment were measured by a series of questions; the answer was dichotomic or ranked by patients. For most questions, the answers to be selected were yes, no, or do not know, and some questions had some items to be ranked (Supplementary material). Dyspnea severity was measured by the mMRC Dyspnea Index. Stages of COPD were defined according to the original GOLD criteria based on FEV 1 % predicted. 21 The investigators in each center were 
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gender difference on the knowledge, attitude, and practice of COPD trained before the study. Patients were interviewed face to face by the investigators.
statistical analyses
All statistical analyses were conducted with SPSS 21.0 (IBM Corporation, Armonk, NY, USA). Descriptive data were expressed as mean±SD or proportion (%). Differences between the two groups were tested using the Student's t-test or the chi-squared test, when appropriate. The independent effects of gender on the knowledge, attitude, and practice of COPD were evaluated with logistic regression models. All P-values were two-tailed, with P0.05 considered statistically significant.
Results

Patients' demographics
Two thousand and seventy-two patients were interviewed in the eleven centers. The final effective questionnaires were 1,698 after exclusion of 337 cases without PFT results and 38 cases who did not meet the COPD PFT criterion ( Figure 1 ). The characteristics of the patients are shown in Patients' knowledge about COPD diagnosis
Patients' knowledge about COPD diagnosis was assessed by the items that were heard of COPD and the risk factors Table 3 .
Patients' knowledge about COPD treatment Table 5 .
Patients' and physicians' practice on COPD treatment
With regard to the practice on COPD treatment, 84.8% female and 87.5% male patients reported use of any respiratory medication for COPD in recent 3 months. The most commonly used drug by women and men was theophylline (54.3% vs 59.1%), followed by salbutamol (36.7% vs 39.0%), ipratropium among male patients and having insurance (OR 0.273, 95% CI 0.123-0.604) among female patients remained the independent variables associated with patients' knowledge on COPD (Table 6 ).
Discussion
The surveys represented the first coordinated national surveys of gender difference on knowledge, attitude, and practice of COPD in China. It revealed that female and male patients had different experiences on COPD and its treatment. The 
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gender difference on the knowledge, attitude, and practice of COPD prevalence (11.9%) than women (5.4%). 2 Women had a poorer understanding of their condition than men; less female patients had a PFT done before than male patients. 2 These two national surveys identified the prevalence of COPD in China and its risk factors, but did not focus on the gender difference of COPD, and our study made a further investigation on the gender difference of COPD. The confronting COPD international survey was performed in the USA, Canada, France, Italy, Germany, the Netherlands, Spain, and the UK in 2000 with 3,265 COPD participants. Forty-one percent of them were women. Women were younger and had lesser pack-years of smoking. They were more likely to report severe dyspnea than men, with similar cough and less sputum. There were no differences in the risk of hospitalization or emergency room visit. 24 Also, there were significant differences in the clinical expression of COPD between men and women, with women scoring lower on health status questionnaires, manifesting worse dyspnea scores, and experiencing more exacerbations than men. 25 A study from Spain showed that women COPD patients were significantly younger, had better PTF, smoked less, but had worse quality of life and higher anxiety and depression. 26 Another probe revealed that at the same age and FEV 1 % predicted, women were more likely to have dyspnea and worse quality of life (the St George's respiratory questionnaire and SF-36 health survey questionnaire) and worse scores on the Morale Scale that measures subjective well-being, but less sputum. 27 Evidence indicates that men and women may be phenotypically different in their response to tobacco smoke, with men being more prone to an emphysematous phenotype and women to an airway predominant phenotype. 18 Also, women were more knowledge on COPD was poor in COPD patients, more measures should be taken to improve patients' knowledge on COPD, especially women. It is evident that gender differences in disease impact, expression, progression, and response to therapy were noted in COPD. 22 However, studies on gender difference in experience and management are lacking. Focused investigation in this area is clearly warranted. Studies suggested that COPD had different impacts on patient physiology and psychology between males and females. In the present study, relative to male patients, female patients were younger, had higher body mass index, were more never smokers, and had lesser pack-years. More female patients were farmers, with under elementary education level, a monthly income of 1,000 RMB, and without medical insurance or work. Although female patients had higher FEV 1 /FVC, FEV 1 %, vital capacity %, and lower residual volume/total lung capacity, they had similar mMRC dyspnea score, the number of exacerbations in the past year, and lower SF-36 mental component summary. The gender differences on COPD were also revealed in other surveys. Our large national survey conducted in 2014-2015 estimated that the prevalence of COPD in Chinese people aged 40 years and older was 13.6%. 23 In the study, there were great differences between men and women in the prevalence, the smoking status, and the severity of COPD. The prevalence of COPD in men was 19.0%, whereas it was 8.1% among women; as to the smoking status, almost all current smokers were men (58.2%), whereas only 4.0% were women, and men had a higher prevalence in COPD of GOLD stage II-IV than women. 23 Another national prevalence study undertaken in 2012-2015 showed similar results, that men had a higher 
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Jia et al likely to be undiagnosed by general practitioners. 15 These studies indicated that gender differences in COPD physiology and psychology existed in different studies. Female COPD patients should be given more attention.
In the study, we used knowledge, attitude, and practice (KAP) questionnaire to evaluate patients' knowledge, attitude, and practice on COPD, instead of validated questionnaires such as the Bristol COPD Knowledge Questionnaire (BCKQ) for some reasons. The BCKQ contains 13 topics and it is widely used to assess patients' knowledge about COPD. It also works well in assessing the effectiveness of education and enables comparison of different teaching methods. 28 Because it focuses on the education of COPD knowledge, it has limitation in assessing COPD patients' attitude and practice and it is not close enough to the clinic to some extent. The KAP questionnaire we used in the article is more comprehensive and closer to clinic than BCKQ, so we chose the KAP questionnaire instead of validated questionnaires such as BCKQ.
Our results showed that COPD patients had a poor understanding of COPD assessed by the items they heard of COPD, the risk factors of COPD, knowledge of the side effects, and COPD treatment. Other studies also showed the same results. A study conducted in Guizhou and Chongqing, China, revealed patients' knowledge on COPD measured by BCKQ and found that patients' knowledge about COPD was poor, the mean BCKQ score was 30.36±5.59, and patients' knowledge level was a risk factor of anxiety and depression. 29 Another study recruited 100 patients in Hong Kong, China, to assess patients' knowledge of COPD, the mean score of BCKQ was 41.01±10.64, and there was no gender difference on the knowledge of COPD. 30 The two Chinese surveys had some limitations in evaluating patients' knowledge on COPD, the number of participants was limited, and most participants were from a single center which could not represent national population. Another survey undertaken in the West Midlands, UK, investigated self-management behavior and support among COPD patients and explored the behavior associated with having a self-management plan. The results indicated that the knowledge on COPD was also poor with a mean BCKQ of 31.5±10.7. 31 A study showed that COPD education delivered in primary care increased patients' knowledge on COPD; the participants' BCKQ scores in the experimental group and the control group were 27.6±8.7 and 29.6±7.9, respectively, at baseline. 32 In general, the knowledge on COPD was limited worldwide, and our survey found that patients, especially women, had a poor knowledge of COPD in China. We should pay more attention to women's education on COPD.
The current survey revealed the differences in male and female patients' attitudes about COPD. Relative to male patients, more female patients reported having never heard of COPD before, not repeating PFT annually, and being unknown to the PFT results. Less female patients had done PFT before and reported that the physician would tell them they have emphysema or COPD. The results were consistent with our previous study in Yanqing District, China. 33 We evaluated the patients' comprehension, recognition, and burden of COPD in the rural area of Beijing. Of the 1,624 people aged 40 in five villages in Yanqing District of Beijing, 148 were diagnosed to have COPD. None of them had ever heard the term COPD and been diagnosed with COPD. Lung function tests and health education had never been performed for these patients. 33 In our national epidemiology survey, about 9.7% of adults had a PTF done before; 2 but in our survey, we found a higher rate of PFT done before than other national and international surveys, 2, 23, 34 which may be attributed to the reason that patients recruited were from clinics in tertiary hospitals and some of them may have visited physicians in primary care or secondary hospitals before. Despite this, over 70% of patients did not know their PFT results. Patients' knowledge of COPD was limited. Patients considered themselves to be uninformed about COPD and obtained most of their information from physicians. A nationwide survey in the USA showed that about 45.6% of the COPD patients were aware of COPD guidelines, but men were better informed. 35 Also, they had sufficient sources of COPD education, as along with physician, respiratory therapist, and nurse, they also got information about COPD on books, magazines, other patients, television or cable, patient organizations, online support groups, and other Internet resources. 35 The results showed that patients had a poor understanding of COPD in China and patients had a few sources, except from the physician, for learning about COPD. Health education should play an important role in the management of COPD in China, particularly among females.
Whether women received the same medical care for COPD as men is not known. We found that the most commonly used drugs by female and male patients in the recent 3 months were theophylline, followed by albuterol, ipratropium bromide, and salmeterol/fluticasone. The results were equal to another survey conducted in Sweden, which showed that drug treatment depended on disease severity. 36 More than 70% of the patients were satisfied with COPD drugs. Approximately 80% of the patients did not know the side effects of anticholinergic drugs, β-adrenergic agonists, ICSs, ICS/long-acting β2-agonist, and theophylline. Similar 
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gender difference on the knowledge, attitude, and practice of COPD percentage of female and male patients reported using antibiotics very often. They did not have oxygen supply at home. Relative to male patients, more female patients reported not having had pulmonary rehabilitation before and lesser number of females reported COPD should be given combined therapy and long-term treatment. In our previous study in Yanqing District, only 4.1% of the patients in stable stage took theophylline irregularly. 33 None of the stable COPD patients took inhalers regularly or temporally. No oxygen therapy and pulmonary rehabilitation were done in those patients. During acute exacerbations, only 6.8% took theophylline and 6.8% had antibiotics, and the management of both stable and exacerbation of COPD was inadequate. 33 The results indicated that patients, especially women, were unfamiliar with COPD guidelines.
In our study, more women were farmers, with under elementary education level, a monthly income 1,000 RMB, and without medical insurance or work. Using "never heard of COPD before" as the outcome variable about patients' knowledge on COPD, we did logistic regression analysis and found that lower income and FEV 1 % in male patients had a negative effect on the knowledge of COPD, and self-paid insurance in female and male patients enhanced patients' knowledge on COPD. Optimal care is impeded by suboptimal knowledge of physicians and patients and by not having insurance coverage policies.
The current study had several limitations. The study design was not a population survey, and patients were selected from clinics in hospitals consecutively and not by random selection; therefore, it might have a selection bias. About 50%-60% of the patients were GOLD stage III and IV; they may have different perceptions of COPD and treatment, compared with stage I and II patients. Secondly, there is heterogeneity in drug availability in different centers. We did not compare the differences among centers.
Conclusion
In summary, our data indicate that male and female patients had different experiences on COPD and its treatment. Physician should pay more attention to patient education, especially of females, using various ways such as television, Internet, and lecture to improve their knowledge and management of COPD.
